Drugs / PSMA/PRAME
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00423254 | Feb 2007 → Sep 2009 | anal carcinoma, biliary tract cancer, bone sarcoma, breast carcinoma +14 | Mannkind Corporation | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PSMA/PRAME | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00423254 ↗ |